# FDA Inspection 1016106 - Adamas Pharmaceuticals, Inc. - April 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/adamas-pharmaceuticals-inc/bddd2c28-0667-4ffb-9c9f-61fd6dbdb852
Source feed: FDA_Inspections

> FDA Inspection 1016106 for Adamas Pharmaceuticals, Inc. on April 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1016106
- Company Name: Adamas Pharmaceuticals, Inc.
- Inspection Date: 2017-04-26
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1145782 - 2021-06-28](https://www.keypedia.com/records/fda_inspections/adamas-pharmaceuticals-inc/92910604-c24f-427d-8076-8f059017ec45)

Company: https://www.keypedia.com/companies/adamas-pharmaceuticals-inc/b3c0a41e-8acd-4829-8f5d-00244c475ee8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c